Tag: biosimilar vs generic
Adverse Event Monitoring for Biosimilars: How Safety Surveillance Works Today
Biosimilars require specialized safety monitoring due to their complex biology. Learn how adverse event reporting, traceability, and real-world surveillance systems ensure patient safety while expanding access to affordable biologic treatments.
What Are Biosimilars? A Simple Guide for Patients
Biosimilars are highly similar versions of complex biologic drugs, approved by the FDA to be as safe and effective as the original. Unlike generics, they’re not exact copies but offer major cost savings without compromising care.